154 related articles for article (PubMed ID: 8143996)
1. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder.
Camilleri M; Balm RK; Zinsmeister AR
Gastroenterology; 1994 Apr; 106(4):916-23. PubMed ID: 8143996
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility.
Camilleri M; Balm RK; Zinsmeister AR
Aliment Pharmacol Ther; 1996 Jun; 10(3):403-9. PubMed ID: 8791970
[TBL] [Abstract][Full Text] [Related]
3. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.
Wiseman LR; Faulds D
Drugs; 1994 Jan; 47(1):116-52. PubMed ID: 7510617
[TBL] [Abstract][Full Text] [Related]
4. GI motility disorders: diagnostic workup and use of prokinetic therapy.
Räihä I; Sourander L
Geriatrics; 1993 Nov; 48(11):57-60, 65-6. PubMed ID: 7901129
[TBL] [Abstract][Full Text] [Related]
5. Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction.
Camilleri M; Balm RK; Low PA
Clin Auton Res; 1993 Apr; 3(2):95-100. PubMed ID: 8324379
[TBL] [Abstract][Full Text] [Related]
6. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.
Camilleri M; Malagelada JR; Abell TL; Brown ML; Hench V; Zinsmeister AR
Gastroenterology; 1989 Mar; 96(3):704-12. PubMed ID: 2644150
[TBL] [Abstract][Full Text] [Related]
7. Cisapride in children with chronic intestinal pseudoobstruction. An acute, double-blind, crossover, placebo-controlled trial.
Di Lorenzo C; Reddy SN; Villanueva-Meyer J; Mena I; Martin S; Hyman PE
Gastroenterology; 1991 Dec; 101(6):1564-70. PubMed ID: 1955122
[TBL] [Abstract][Full Text] [Related]
8. [Prokinetic drugs].
Hellström P
Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341
[TBL] [Abstract][Full Text] [Related]
9. Influence of cisapride on antroduodenal motor function in healthy subjects and diabetics with autonomic neuropathy.
Wehrmann T; Lembcke B; Caspary WF
Aliment Pharmacol Ther; 1991 Dec; 5(6):599-608. PubMed ID: 1782304
[TBL] [Abstract][Full Text] [Related]
10. Effects of cisapride on symptoms and postcibal small-bowel motor function in patients with irritable bowel syndrome.
Noor N; Small PK; Loudon MA; Hau C; Campbell FC
Scand J Gastroenterol; 1998 Jun; 33(6):605-11. PubMed ID: 9669632
[TBL] [Abstract][Full Text] [Related]
11. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.
McCallum RW; Prakash C; Campoli-Richards DM; Goa KL
Drugs; 1988 Dec; 36(6):652-81. PubMed ID: 3065057
[TBL] [Abstract][Full Text] [Related]
12. Placebo-controlled trial of cisapride in postoperative ileus.
Boghaert A; Haesaert G; Mourisse P; Verlinden M
Acta Anaesthesiol Belg; 1987; 38(3):195-9. PubMed ID: 3321849
[TBL] [Abstract][Full Text] [Related]
13. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
[TBL] [Abstract][Full Text] [Related]
14. Small bowel motility following major intra-abdominal surgery: the effects of opiates and rectal cisapride.
Benson MJ; Roberts JP; Wingate DL; Rogers J; Deeks JJ; Castillo FD; Williams NS
Gastroenterology; 1994 Apr; 106(4):924-36. PubMed ID: 8143997
[TBL] [Abstract][Full Text] [Related]
15. Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction.
Hyman PE; Di Lorenzo C; McAdams L; Flores AF; Tomomasa T; Garvey TQ
Am J Gastroenterol; 1993 Jun; 88(6):832-6. PubMed ID: 8503375
[TBL] [Abstract][Full Text] [Related]
16. Cisapride in chronic dyspepsia: results of a double-blind, placebo-controlled trial.
Chung JM
Scand J Gastroenterol Suppl; 1993; 195():11-4. PubMed ID: 8516653
[TBL] [Abstract][Full Text] [Related]
17. Effect of cisapride on chronic idiopathic constipation in children.
Staiano A; Cucchiara S; Andreotti MR; Minella R; Manzi G
Dig Dis Sci; 1991 Jun; 36(6):733-6. PubMed ID: 2032513
[TBL] [Abstract][Full Text] [Related]
18. Double-blind placebo-controlled study of cisapride in patients with nonspecific esophageal motility disorder accompanied by delayed esophageal transit.
Song CW; UM SH; Kim CD; Ryu HS; Hyun JH; Choe JG
Scand J Gastroenterol; 1997 Jun; 32(6):541-6. PubMed ID: 9200284
[TBL] [Abstract][Full Text] [Related]
19. "Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride.
Van Outryve M; Milo R; Toussaint J; Van Eeghem P
J Clin Gastroenterol; 1991 Feb; 13(1):49-57. PubMed ID: 2007745
[TBL] [Abstract][Full Text] [Related]
20. Effect of cisapride on distal colonic motility in the early postoperative period following left colonic anastomosis.
Roberts JP; Benson MJ; Rogers J; Deeks JJ; Wingate DL; Williams NS
Dis Colon Rectum; 1995 Feb; 38(2):139-45. PubMed ID: 7851167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
